Crohn's Disease

J&J advances Stelara succession scheme with key FDA nod for Tremfya in Crohn's disease
Fierce Pharma
Thu, 03/20/25 - 10:03 pm
JNJ
Tremfya
FDA
Crohn's Disease
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
MSN/Reuters
Fri, 02/21/25 - 11:18 am
Teva Pharmaceutical
Alvotech
biosimilars
Stelara
autoimmune disease
Selarsdi
Crohn's Disease
ulcerative colitis
plaque psoriasis
Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease
Clinical Trials Arena
Mon, 02/10/25 - 10:17 am
Eli Lilly
Crohn's Disease
clinical trials
Omvoh
Takeda backs biomarker trial for Crohn's prevention
Pharmaphorum
Wed, 01/22/25 - 11:18 am
Takeda
biomarkers
Crohn's Disease
Lilly's Omvoh scores second IBD win with FDA nod in Crohn's
First Word Pharma
Wed, 01/15/25 - 11:50 pm
Eli Lilly
Omvoh
IBD
FDA
Crohn's Disease
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Mon, 10/28/24 - 06:24 pm
Eli Lilly
JNJ
Crohn's Disease
FDA
clinical trials
Tremfya
Omvoh
On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study
Fierce Pharma
Tue, 10/15/24 - 10:15 am
Eli Lilly
Crohn's Disease
Omvoh
clinical trials
JNJ
Stelara
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
AbbVie
Skyrizi
Crohn's Disease
psoriatic arthritis
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease
BioSpace
Tue, 07/30/24 - 11:34 am
Ventyx Biosciences
VTX958
Crohn's Disease
J&J Positions Tremfya as Stelara Successor with Strong Head-to-Head Data
BioSpace
Wed, 05/22/24 - 11:33 am
JNJ
Tremfya
Stelara
Crohn's Disease
Bristol Myers' bowel disease drug fails to meet main goal in late-stage study
Reuters
Thu, 03/28/24 - 05:07 pm
Bristol Myers Squibb
Crohn's Disease
clinical trials
ozanimod
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
Pharm
Mon, 10/23/23 - 05:20 pm
Celltrio
Zymfentra
ulcerative colitis
Crohn's Disease
biosimilars
Remicade
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Thu, 10/19/23 - 10:07 am
Takeda
Crohn's Disease
Alofisel
clinical trials
stem cells
Janssen’s Tremfya maintains three years of remission in Phase II Crohn’s disease trial
Clinical Trials Arena
Tue, 10/17/23 - 11:45 am
JNJ
Janssen
clinical trials
Crohn's Disease
Tremfya
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
Mon, 10/16/23 - 11:50 am
AbbVie
Akyrizi
JNJ
Stelara
Crohn's Disease
Lilly’s Mirikizumab Shows Long-Term Remission in Phase III Crohn’s Trial
BioSpace
Thu, 10/12/23 - 05:22 pm
Eli Lilly
mirikizumab
Crohn's Disease
FDA
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
Fri, 09/8/23 - 11:29 am
AbbVie
Humira
biosimilars
Crohn's Disease
Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report
BioSpace
Fri, 07/14/23 - 11:56 am
Roche
Roivant
ulcerative colitis
Crohn's Disease
M&A

Pages